PRESENTATIONS | PUBLICATIONS| POSTERS
RECENTLY PUBLISHED
Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples
poster
Nov 13, 2019
Vijayendra Agrawal Ph.D. , Mibel Pabon, Ph.D. , Tina Pastoor, M.S , Jenny Kreahl...
Impact of Combined Blockade of PD1 and Activation of CD137 on Tumor Infiltration and Tumor Cell Killing Efficacy of Tumor Infiltrating Lymphocytes (TILs) in an Ex Vivo Autologous 3D Tumoroid Model of NSCLC Patient Samples.
poster
Nov 13, 2019
Melba Marie Page, Ph.D., Vijayendra Agrawal Ph.D., Mibel Pabón, Ph.D. , Tina Pa...
Functional 3D-plEX Quantitative Multiplex Immunofluorescence Platform to Assess Immuno-oncology Drug Impact on Tumor Microenvironment in Ex Vivo Treated Intact 3D-tumor Organoids of Fresh Patient Tumor Tissue
poster
Nov 13, 2019
Vijayendra Agrawal Ph.D., Mibel Pabón, Ph.D. , Tina Pastoor , Jenny Kreahling, ...
A Patient-driven Ex Vivo 3D Tumor Organoid Model to Assess Efficacy of Tumor Infiltrating T-cell Adoptive Cell Therapy
poster
Nov 13, 2019
Mibel Pabón, Ph.D. , Vijayendra Agrawal Ph.D., Tina Pastoor, Jenny Kreahling, P...
Impact of CDK4/6 inhibition on tumor immune microenvironment and immunomodulatory effects of PDL-1 blockade in a physiologically relevant 3D-tumoroid model of fresh patient tumor ex vivo.
poster
Apr 29, 2019
Melba Marie Page Ph.D, Melanie Mediavilla-Varela Ph.D, Vijayendra Agrawal Ph.D, ...
The importance of intact tumor immune microenvironment in unpropagated 3D fresh patient tumoroids for immuno-oncology drug testing
poster
Mar 31, 2019
Melanie Mediavilla-Varela Ph.D., Vijayendra Agrawal Ph.D., Melba Marie Page Ph.D...
A high-content imaging platform for quantitative assessment of immunogenic tumor cell killing and T-cell proliferation in 3D tumoroids of fresh patient tumor samples
poster
Mar 31, 2019
Melanie Mediavilla-Varela Ph.D., Vijayendra Agrawal Ph.D., Melba Marie Page Ph.D...
A novel high-throughput, high-content real time imaging platform to assess immunogenic cell killing activity of immunotherapeutic agents using patient-derived tumor samples
poster
Nov 11, 2018
Melanie Mediavilla Varela, Melba Marie Page, Jenny Kreahling, Scott Antonia and ...
Innovative combinatorial approach to characterize the immune landscape and analyze the tumor response after anti-PD1 blockade in a 3D Ex-Vivo tumoroid system of non-small cell lung cancer
poster
Nov 11, 2018
Melba Marie Page Ph.D., Melanie Mediavilla-Varela Ph.D., Jenny Kreahling, Ph.D.,...
Integrated Comprehensive Analysis of Immune Cell subsets and Assessment of Keytruda Response in Head and Neck Squamous Cell Carcinoma, Urothelial Cell Carcinoma, and Renal Cell Carcinoma Ex-vivo
poster
Apr 18, 2018
Melba Marie Page Ph.D., Melanie Mediavilla-Varela Ph.D., Soner Altiok, M.D., Ph....
Characterization of the Immune Landscape and Analysis of Tumor Response After Anti-PD-1 Blockade in a 3D Ex-Vivo System of Non-Small Cell Lung Cancer
poster
Apr 18, 2018
Melanie Mediavilla-Varela Ph.D., Melba Marie Page Ph.D., Jenny Kreahling, Ph.D.,...
LEARN MORE FROM US
Learn more about Nilogen’s work in immuno-oncology drug development.